SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
Democratic Presidential hopeful Sen. Elizabeth Warren gestures as she speaks during a town hall meeting at Florida International University in Miami, Florida on June 25, 2019. (Photo: Rhona Wise / AFP)
After Trump's Former FDA Chief Quietly Joins Pfizer Board, Warren Calls for Resignation 'Immediately'
"I ask that you reconsider this decision," 2020 candidate tells former Trump official
Jul 02, 2019
Maybe Scott Gottleib thought he could avoid scrutiny by making the move to the board of pharmaceutical giant Pfizer just over two months after leaving his position as President Donald Trump's commissioner of the U.S. Food and Drug Administration--but if so, he didn't count on Sen. Elizabeth Warren.
"Philosophically, [Gottleib is] returning to the ecosystem where he's most comfortable. And he'll get paid very well for it, too."
--Sidney Wolfe, Public Citizen
Warren, a Democrat from Massachusetts who is also running for her party's nomination for president in 2020, released a letter (pdf) Tuesday morning calling on Gottleib to step down from the board in the name of government ethics.
"You will be on the board of a company that has billions of dollars at stake in the decisions made by the agency you used to head and the employees you used to lead," states Warren's letter.
It's a profitable venture for Gottleib.
"According to Pfizer," Warren notes, "board members in 2018 were paid $142,500 in cash retainers, plus received $192,500 worth of Pfizer stock."
Appointed by Trump, Gottleib was the head of the FDA from 2017 until he resigned on April 5 of this year. After leaving the government, he took a job with right-wing think tank The American Enterprise Institute. The move to Pfizer, however, came later and was only announced on June 27.
In Warren's letter, which Common Dreams obtained exclusively and is reproduced below, the senator refers favorably to Gottleib's work with the FDA before hitting him on joining Pfizer and tying that move to the behavior of other officials in President Donald Trump's White House who have left the administration for big money payouts.
"You are the second high-level Trump Administration official in less than two months to join the board of a corporation soon after leaving government service," reads the letter. "In May 2019, former Trump Administration DHS Secretary and Chief of Staff John Kelly joined the board of Caliburn, Inc., the parent company of the Comprehensive Health Services, which runs the notorious Homestead Temporary Shelter for Unaccompanied Children in Florida."
"You should rectify your mistake and immediately resign from your position as a Pfizer board member," Warren adds.
Warren's letter cites her Anti-Corruption and Public Integrity Act as a possible solution to government officials behaving in this way in the future. As Common Dreams reported in June, Warren and the legislation's sponsor in the House, Rep. Pramila Jayapal (D-Wash.), see the problem as systemic to Washington's public-private revolving door. Rep. John Sabarnes (D-Md.) is co-sponsoring Jayapal's version of the law.
Gottleib's move to Pfizer was also noticed by Public Citizen Health Research Group co-founder Sidney Wolfe.
"This is classic and it's not surprising," Wolfe told health news site Stat. "Philosophically, he's returning to the ecosystem where he's most comfortable. And he'll get paid very well for it, too."
Read Warren's letter:
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, The U.S. is on a fast track to authoritarianism like nothing I've ever seen. Meanwhile, corporate news outlets are utterly capitulating to Trump, twisting their coverage to avoid drawing his ire while lining up to stuff cash in his pockets. That's why I believe that Common Dreams is doing the best and most consequential reporting that we've ever done. Our small but mighty team is a progressive reporting powerhouse, covering the news every day that the corporate media never will. Our mission has always been simple: To inform. To inspire. And to ignite change for the common good. Now here's the key piece that I want all our readers to understand: None of this would be possible without your financial support. That's not just some fundraising cliche. It's the absolute and literal truth. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. Will you donate now to help power the nonprofit, independent reporting of Common Dreams? Thank you for being a vital member of our community. Together, we can keep independent journalism alive when it’s needed most. - Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
Maybe Scott Gottleib thought he could avoid scrutiny by making the move to the board of pharmaceutical giant Pfizer just over two months after leaving his position as President Donald Trump's commissioner of the U.S. Food and Drug Administration--but if so, he didn't count on Sen. Elizabeth Warren.
"Philosophically, [Gottleib is] returning to the ecosystem where he's most comfortable. And he'll get paid very well for it, too."
--Sidney Wolfe, Public Citizen
Warren, a Democrat from Massachusetts who is also running for her party's nomination for president in 2020, released a letter (pdf) Tuesday morning calling on Gottleib to step down from the board in the name of government ethics.
"You will be on the board of a company that has billions of dollars at stake in the decisions made by the agency you used to head and the employees you used to lead," states Warren's letter.
It's a profitable venture for Gottleib.
"According to Pfizer," Warren notes, "board members in 2018 were paid $142,500 in cash retainers, plus received $192,500 worth of Pfizer stock."
Appointed by Trump, Gottleib was the head of the FDA from 2017 until he resigned on April 5 of this year. After leaving the government, he took a job with right-wing think tank The American Enterprise Institute. The move to Pfizer, however, came later and was only announced on June 27.
In Warren's letter, which Common Dreams obtained exclusively and is reproduced below, the senator refers favorably to Gottleib's work with the FDA before hitting him on joining Pfizer and tying that move to the behavior of other officials in President Donald Trump's White House who have left the administration for big money payouts.
"You are the second high-level Trump Administration official in less than two months to join the board of a corporation soon after leaving government service," reads the letter. "In May 2019, former Trump Administration DHS Secretary and Chief of Staff John Kelly joined the board of Caliburn, Inc., the parent company of the Comprehensive Health Services, which runs the notorious Homestead Temporary Shelter for Unaccompanied Children in Florida."
"You should rectify your mistake and immediately resign from your position as a Pfizer board member," Warren adds.
Warren's letter cites her Anti-Corruption and Public Integrity Act as a possible solution to government officials behaving in this way in the future. As Common Dreams reported in June, Warren and the legislation's sponsor in the House, Rep. Pramila Jayapal (D-Wash.), see the problem as systemic to Washington's public-private revolving door. Rep. John Sabarnes (D-Md.) is co-sponsoring Jayapal's version of the law.
Gottleib's move to Pfizer was also noticed by Public Citizen Health Research Group co-founder Sidney Wolfe.
"This is classic and it's not surprising," Wolfe told health news site Stat. "Philosophically, he's returning to the ecosystem where he's most comfortable. And he'll get paid very well for it, too."
Read Warren's letter:
Maybe Scott Gottleib thought he could avoid scrutiny by making the move to the board of pharmaceutical giant Pfizer just over two months after leaving his position as President Donald Trump's commissioner of the U.S. Food and Drug Administration--but if so, he didn't count on Sen. Elizabeth Warren.
"Philosophically, [Gottleib is] returning to the ecosystem where he's most comfortable. And he'll get paid very well for it, too."
--Sidney Wolfe, Public Citizen
Warren, a Democrat from Massachusetts who is also running for her party's nomination for president in 2020, released a letter (pdf) Tuesday morning calling on Gottleib to step down from the board in the name of government ethics.
"You will be on the board of a company that has billions of dollars at stake in the decisions made by the agency you used to head and the employees you used to lead," states Warren's letter.
It's a profitable venture for Gottleib.
"According to Pfizer," Warren notes, "board members in 2018 were paid $142,500 in cash retainers, plus received $192,500 worth of Pfizer stock."
Appointed by Trump, Gottleib was the head of the FDA from 2017 until he resigned on April 5 of this year. After leaving the government, he took a job with right-wing think tank The American Enterprise Institute. The move to Pfizer, however, came later and was only announced on June 27.
In Warren's letter, which Common Dreams obtained exclusively and is reproduced below, the senator refers favorably to Gottleib's work with the FDA before hitting him on joining Pfizer and tying that move to the behavior of other officials in President Donald Trump's White House who have left the administration for big money payouts.
"You are the second high-level Trump Administration official in less than two months to join the board of a corporation soon after leaving government service," reads the letter. "In May 2019, former Trump Administration DHS Secretary and Chief of Staff John Kelly joined the board of Caliburn, Inc., the parent company of the Comprehensive Health Services, which runs the notorious Homestead Temporary Shelter for Unaccompanied Children in Florida."
"You should rectify your mistake and immediately resign from your position as a Pfizer board member," Warren adds.
Warren's letter cites her Anti-Corruption and Public Integrity Act as a possible solution to government officials behaving in this way in the future. As Common Dreams reported in June, Warren and the legislation's sponsor in the House, Rep. Pramila Jayapal (D-Wash.), see the problem as systemic to Washington's public-private revolving door. Rep. John Sabarnes (D-Md.) is co-sponsoring Jayapal's version of the law.
Gottleib's move to Pfizer was also noticed by Public Citizen Health Research Group co-founder Sidney Wolfe.
"This is classic and it's not surprising," Wolfe told health news site Stat. "Philosophically, he's returning to the ecosystem where he's most comfortable. And he'll get paid very well for it, too."
Read Warren's letter:
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.